Binu Koirala1, Bryan R Hansen1, Annmarie Hosie2, Chakra Budhathoki1, Stella Seal3, Adam Beaman1,4, Patricia M Davidson1,4. 1. Johns Hopkins School of Nursing, Baltimore, Maryland. 2. School of Nursing Sydney, The University of Notre Dame Australia, Darlinghurst, NSW, Australia. 3. Johns Hopkins University and Medicine Welch Medical Library, Baltimore, Maryland. 4. University of Technology Sydney, Sydney, NSW, Australia.
Abstract
AIMS: To examine the delirium point prevalence studies conducted in different inpatient settings and to discuss the implication of the findings for delirium screening, assessment, prevention and management. BACKGROUND: Delirium-a common and distressing condition manifesting as an acute decline of attention and cognition-is frequently overlooked, misdiagnosed or treated inappropriately. This neuropsychiatric syndrome manifests as changes in attention, cognition and awareness, with resultant impact on behaviour, function and emotions. Delirium is recognised as a patient management challenge in the inpatient setting, and there is a need to understand the current point prevalence and assessment practices of delirium. DESIGN: A systematic review and meta-analysis. METHODS: A systematic review of published delirium prevalence studies in inpatient settings was conducted and the implications of findings for delirium screening, assessment, prevention and management identified. The random-effects meta-analysis was conducted among studies measuring delirium point prevalence. The PRISMA statement was used to report systematic review and meta-analysis. RESULTS: Nine studies were included in the review, with sample sizes ranging from 47-1867. Delirium point prevalence ranged from 9%-32%. Hypoactive delirium was the most common subtype, ranging from 23%-78%. Fifteen delirium screening tools or assessment or diagnostic methods were used. Comorbid dementia was present in up to 50% of inpatients. CONCLUSIONS: Gaining a consensus on effective delirium instruments, the time windows for assessment and measurement will be crucial in driving benchmarking and quality improvement studies. RELEVANCE TO CLINICAL PRACTICE: Consistent identification of high-risk patients and treatment settings with elevated risk, accompanied by the implementation of effective preventive and management strategies, are critical to addressing delirium-a frequent and burdensome condition, that adversely affects patient outcomes.
AIMS: To examine the delirium point prevalence studies conducted in different inpatient settings and to discuss the implication of the findings for delirium screening, assessment, prevention and management. BACKGROUND:Delirium-a common and distressing condition manifesting as an acute decline of attention and cognition-is frequently overlooked, misdiagnosed or treated inappropriately. This neuropsychiatric syndrome manifests as changes in attention, cognition and awareness, with resultant impact on behaviour, function and emotions. Delirium is recognised as a patient management challenge in the inpatient setting, and there is a need to understand the current point prevalence and assessment practices of delirium. DESIGN: A systematic review and meta-analysis. METHODS: A systematic review of published delirium prevalence studies in inpatient settings was conducted and the implications of findings for delirium screening, assessment, prevention and management identified. The random-effects meta-analysis was conducted among studies measuring delirium point prevalence. The PRISMA statement was used to report systematic review and meta-analysis. RESULTS: Nine studies were included in the review, with sample sizes ranging from 47-1867. Delirium point prevalence ranged from 9%-32%. Hypoactive delirium was the most common subtype, ranging from 23%-78%. Fifteen delirium screening tools or assessment or diagnostic methods were used. Comorbid dementia was present in up to 50% of inpatients. CONCLUSIONS: Gaining a consensus on effective delirium instruments, the time windows for assessment and measurement will be crucial in driving benchmarking and quality improvement studies. RELEVANCE TO CLINICAL PRACTICE: Consistent identification of high-risk patients and treatment settings with elevated risk, accompanied by the implementation of effective preventive and management strategies, are critical to addressing delirium-a frequent and burdensome condition, that adversely affects patient outcomes.
Authors: Zoë Tieges; Alasdair M J Maclullich; Atul Anand; Claire Brookes; Marica Cassarino; Margaret O'connor; Damien Ryan; Thomas Saller; Rakesh C Arora; Yue Chang; Kathryn Agarwal; George Taffet; Terence Quinn; Susan D Shenkin; Rose Galvin Journal: Age Ageing Date: 2020-11-11 Impact factor: 10.668
Authors: Amy Montgomery; Jo-Anne Todd; Cindy Jones; June Koroitamana; Laurie Grealish; Anne Wand; Stephen Billett; Andrew Teodorczuk Journal: Age Ageing Date: 2022-02-02 Impact factor: 12.782
Authors: Zoë Tieges; Alasdair M J Maclullich; Atul Anand; Claire Brookes; Marica Cassarino; Margaret O'connor; Damien Ryan; Thomas Saller; Rakesh C Arora; Yue Chang; Kathryn Agarwal; George Taffet; Terence Quinn; Susan D Shenkin; Rose Galvin Journal: Age Ageing Date: 2021-05-05 Impact factor: 10.668
Authors: Filipa Pereira; Henk Verloo; Armin von Gunten; María Del Río Carral; Carla Meyer-Massetti; Maria Manuela Martins; Boris Wernli Journal: BMJ Open Date: 2022-03-04 Impact factor: 2.692